Analyst Ratings For NASDAQ:RDUS – Radius Health (NASDAQ:RDUS)
Today, JPMorgan Chase & Co. raised its price target on NASDAQ:RDUS – Radius Health (NASDAQ:RDUS) to per share.
Some recent analyst ratings include
- 3/29/2018-Leerink Swann initiated coverage with a Outperform ➝ Outperform rating.
- 1/22/2018-Citigroup Reiterated Rating of Hold.
- 10/6/2017-Goldman Sachs Group Reiterated Rating of Neutral ➝ Neutral.
- On 5/23/2018 Growth N V Biotech, Major Shareholder, bought 40,000 with an average share price of $28.91 per share and the total transaction amounting to $1,156,400.00.
- On 5/21/2018 Growth N V Biotech, Major Shareholder, bought 60,000 with an average share price of $29.27 per share and the total transaction amounting to $1,756,200.00.
- On 4/19/2018 Growth N V Biotech, Major Shareholder, bought 40,000 with an average share price of $33.80 per share and the total transaction amounting to $1,352,000.00.
- On 4/5/2018 Growth N V Biotech, Major Shareholder, bought 50,000 with an average share price of $36.58 per share and the total transaction amounting to $1,829,000.00.
- On 3/2/2018 Growth N V Biotech, Major Shareholder, bought 80,000 with an average share price of $32.52 per share and the total transaction amounting to $2,601,600.00.
- On 2/9/2018 Growth N V Biotech, Major Shareholder, bought 75,000 with an average share price of $34.38 per share and the total transaction amounting to $2,578,500.00.
- On 11/14/2017 Growth N V Biotech, Major Shareholder, bought 50,000 with an average share price of $26.25 per share and the total transaction amounting to $1,312,500.00.
Recent Trading Activity for NASDAQ:RDUS – Radius Health (NASDAQ:RDUS)
Shares of NASDAQ:RDUS – Radius Health closed the previous trading session at 28.04 down -0.17 0.60% with 28.5 shares trading hands.